In any event, although in most of the breast cancer cases overexpression of HER2 is due to gene amplification [25], other mechanisms can be involved, including aneuploidies of chromosome 17 [26,27], and/or epigenetic or posttranscriptional events [28,29]. The gene discussed is ERBB2; the disease is breast carcinoma.